Non-receptor tyrosine kinase 2 reaches its lowest expression levels in human breast cancer during regional nodal metastasis

Clinical and Experimental Metastasis

Volumn 29, Issue 2, 2012, Pages 143-153

  Sang, Qing Xiang Amy ^a   Man, Yan Gao ^b,c,d   Sung, You Me ^e   Khamis, Zahraa I ^e   Zhang, Lihua ^e   Lee, Mi Hye ^e   Byers, Stephen W ^e   Sahab, Ziad J ^e  

^a FLORIDA STATE UNIVERSITY   (United States)

^b Diagnostic and Translational Research Center   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

^d JILIN UNIVERSITY   (China)

^e GEORGETOWN UNIVERSITY   (United States)

Author keywords

DCIS; Estrogen receptor ; Proteomics; Tissue microdissection; TYK2

Indexed keywords

ESTROGEN RECEPTOR ALPHA; PROTEIN TYROSINE KINASE; TYROSINE KINASE 2; UNCLASSIFIED DRUG; VALOSIN CONTAINING PROTEIN; PROTEIN KINASE TYK2;

ADULT; ARTICLE; BREAST CANCER; CANCER CELL; CANCER PATIENT; CANCER TISSUE; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CELL LINEAGE; COHORT ANALYSIS; CONTROLLED STUDY; DOWN REGULATION; ENZYME BINDING; FEMALE; GEL ELECTROPHORESIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICRODISSECTION; MYOEPITHELIUM CELL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGIONAL METASTASIS; BREAST TUMOR; ENZYMOLOGY; GENE SILENCING; GENETICS; MASS SPECTROMETRY; METABOLISM; MIDDLE AGED; PATHOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MIDDLE AGED; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TYK2 KINASE;

EID: 84857170028     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-011-9437-1     Document Type: Article

References (31)

1. KA Skinner MJ Silverstein 2001 The management of ductal carcinoma in situ of the breast Endocr Relat Cancer 8 1 33 45 11350725 1:STN:280: DC%2BD3M3lt1Ciuw%3D%3D 10.1677/erc.0.0080033 (Pubitemid 32520252)
2. YG Man QXA Sang 2004 The significance of focal myoepithelial cell layer disruptions in human breast tumor invasion: a paradigm shift from the "protease-centered" hypothesis Exp Cell Res 301 2 103 118 15530847 1:CAS:528:DC%2BD2cXpsVOksL8%3D 10.1016/j.yexcr.2004.08.037 (Pubitemid 39504964)
3. YG Man L Tai R Barner, et al. 2003 Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion Breast Cancer Res 5 6 R231 R241 14580259 1:CAS:528:DC%2BD3sXptFKlu78%3D 10.1186/bcr653
4. YG Man KM Shekitka GL Bratthauer, et al. 2002 Immunohistochemical and genetic alterations in mammary epithelial cells immediately overlying focally disrupted myoepithelial cell layers Breast Cancer Res Treat 76 S143 S153
5. M Yousefi R Mattu CL Gao, et al. 2005 Mammary ducts with and without focal myoepithelial cell layer disruptions show a different frequency of white blood cell infiltration and growth pattern: Implications for tumor progression and invasion Appl Immunohistochem Mol Morphol 13 1 30 37 15722791 10.1097/00129039-200503000-00006 (Pubitemid 40283800)
6. ZJ Sahab YG Man SW Byers, et al. 2011 Putative biomarkers and targets of estrogen receptor negative human breast cancer Int J Mol Sci 12 7 4504 4521 21845093 1:CAS:528:DC%2BC3MXpvFGltL0%3D 10.3390/ijms12074504
7. ZJ Sahab YG Man SM Semaan, et al. 2010 Alteration in protein expression in estrogen receptor alpha-negative human breast cancer tissues indicates a malignant and metastatic phenotype Clin Exp Metastasis 27 7 493 503 20602252 1:CAS:528:DC%2BC3cXht1Slsb%2FM 10.1007/s10585-010-9338-8
8. D Stoiber B Kovacic C Schuster, et al. 2004 TYK2 is a key regulator of the surveillance of B lymphoid tumors J Clin Invest 114 11 1650 1658 15578097 1:CAS:528:DC%2BD2cXhtVKhur3L (Pubitemid 40385556)
9. Wilks AF (1989) 2 Putative protein-tyrosine kinases identified by application of the polymerase chain-reaction. In: Proceedings of the National Academy of Sciences of the United States of America 86(5): 1603-1607 (Pubitemid 19078951)
10. ZJ Sahab Y Suh QXA Sang 2005 Isoelectric point-based prefractionation of proteins from crude biological samples prior to two-dimensional gel electrophoresis J Proteome Res 4 6 2266 2272 16335975 1:CAS:528: DC%2BD2MXht1ajsr%2FJ 10.1021/pr0501822 (Pubitemid 41814296)
11. ZJ Sahab MD Hall L Zhang, et al. 2010 Tumor suppressor RARRES1 regulates DLG2, PP2A, VCP, EB1, and Ankrd26 J Cancer 1 1 14 22 20842219 1:CAS:528:DC%2BC3cXhtlelt7rN 10.7150/jca.1.14
12. ZJ Sahab KA Iczkowski QXA Sang 2007 Anion exchange fractionation of serum proteins versus albumin elimination Anal Biochem 368 1 24 32 17618595 1:CAS:528:DC%2BD2sXotVWlsbw%3D 10.1016/j.ab.2007.06.004 (Pubitemid 47058437)
13. Khamis ZI, Sahab ZJ, Byers SW, et al (2011) Novel stromal biomarkers in human breast cancer tissues provide evidence for the more malignant phenotype of estrogen receptor-negative tumors. J Biomed Biotechnol 2011:7, Article ID 723650
14. ZJ Sahab MD Hall YM Sung, et al. 2011 Tumor suppressor RARRES1 interacts with cytoplasmic carboxypeptidase AGBL2 to regulate the a-tubulin tyrosination cycle Cancer Res 71 4 1219 1228 21303978 1:CAS:528:DC%2BC3MXhvFSjs7k%3D 10.1158/0008-5472.CAN-10-2294
15. CS Clemen K Tangavelou KH Strucksberg, et al. 2010 Strumpellin is a novel valosin-containing protein binding partner linking hereditary spastic paraplegia to protein aggregation diseases Brain 133 2920 2941 20833645 10.1093/brain/awq222
16. T Rabilloud C Adessi A Giraudel, et al. 1997 Improvement of the solubilization of proteins in two-dimensional electrophoresis with immobilized pH gradients Electrophoresis 18 3-4 307 316 9150907 1:CAS:528:DyaK2sXjtlGnt70%3D 10.1002/elps.1150180303 (Pubitemid 27174413)
17. JN Ihle 1995 Cytokine receptor signaling Nature 377 6550 591 594 7566171 1:CAS:528:DyaK2MXovVGmsbo%3D 10.1038/377591a0
18. I Firmbachkraft M Byers T Shows, et al. 1990 Tyk2, prototype of a novel class of nonreceptor tyrosine kinase genes Oncogene 5 9 1329 1336 1:CAS:528:DyaK3MXhsFyjuro%3D
19. Y Minegishi M Saito T Morio, et al. 2006 Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity Immunity 25 5 745 755 17088085 1:CAS:528: DC%2BD28Xht1Gnt7zI 10.1016/j.immuni.2006.09.009 (Pubitemid 46131400)
20. B Grimbacher SM Holland JI Gallin, et al. 1999 Hyper-IgE syndrome with recurrent infections-an autosomal dominant multisystem disorder N Engl J Med 340 9 692 702 10053178 1:STN:280:DyaK1M7ltVSltQ%3D%3D 10.1056/NEJM199903043400904 (Pubitemid 29110753)
21. MAE Watanabe JMM Oda MK Amarante, et al. 2010 Regulatory T cells and breast cancer: implications for immunopathogenesis Cancer Metastasis Rev 29 4 569 579 20830504 1:CAS:528:DC%2BC3cXhtlant7zP 10.1007/s10555-010-9247-y
22. Ownby D, Ownby H, Roi L, et al (1982) The prognostic value of serum ige levels in primary breast-cancer. In: Proceedings of the American Association for Cancer Research 23: 150-150
23. XC Zhang SS Hashemi M Yousefi, et al. 2009 Atypical E-cadherin expression in cell clusters overlying focally disrupted mammary myoepithelial cell layers: implications for tumor cell motility and invasion Pathol Res Pract 205 6 375 385 19395181 1:CAS:528:DC%2BD1MXmsFKgtLs%3D 10.1016/j.prp.2008.08.009
24. GS Sivko DC Sanford LD Dearth, et al. 2004 CCAAT/enhancer binding protein delta (C/EBP delta) regulation and expression in human mammary epithelial cells: II. Analysis of activating signal transduction pathways, transcriptional, post-transcriptional, and post-translational control J Cell Biochem 93 4 844 856 15389878 1:CAS:528:DC%2BD2cXpvVCgurg%3D 10.1002/jcb.20224 (Pubitemid 44264178)
25. L Tao JY Liu Z Li, et al. 2010 Role of the JAK-STAT pathway in proliferation and differentiation of human hypertrophic scar fibroblasts induced by connective tissue growth factor Mol Med Reports 3 6 941 945 1:CAS:528:DC%2BC3cXhtlCqtLbK
26. BM Chung HC Kang SY Han, et al. 2006 Jak2 and Tyk2 are necessary for lineage-specific differentiation, but not for the maintenance of self-renewal of mouse embryonic stem cells Biochem Biophys Res Commun 351 3 682 688 17078929 1:CAS:528:DC%2BD28Xht1SmsbfL 10.1016/j.bbrc.2006.10.081 (Pubitemid 44780857)
27. H Ide T Nakagawa Y Terado, et al. 2008 Tyk2 expression and its signaling enhances the invasiveness of prostate cancer cells Biochem Biophys Res Commun 369 2 292 296 17920038 1:CAS:528:DC%2BD1cXjs12gtrw%3D 10.1016/j.bbrc.2007.08.160 (Pubitemid 351400466)
28. C Schuster M Muller M Freissinuth, et al. 2008 Tyk2 expression and its signaling enhances the invasiveness of prostate cancer cells Biochem Biophys Res Commun 366 4 869 870 18082134 1:CAS:528:DC%2BD1cXislyntA%3D%3D 10.1016/j.bbrc.2007.12.017
29. MT Nevalainen JW Xie J Torhorst, et al. 2004 Signal transducer and activator of transcription-5 activation and breast cancer prognosis J Clin Oncol 22 11 2053 2060 15169792 1:CAS:528:DC%2BD2cXpsVWls7o%3D 10.1200/JCO.2004.11.046 (Pubitemid 41095137)
30. AS Sultan JW Xie MJ LeBaron, et al. 2005 Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells Oncogene 24 5 746 760 15592524 1:CAS:528:DC%2BD2MXnt1WlsQ%3D%3D 10.1038/sj.onc.1208203 (Pubitemid 40216084)
31. XC Song GY Fu XF Yang, et al. 2008 Protein expression profiling of breast cancer cells by dissociable antibody microarray (DAMA) staining Mol Cellular Proteomics 7 1 163 169 1:CAS:528:DC%2BD1cXhtFOqu7o%3D 10.1074/mcp.M700115-MCP200 (Pubitemid 351248241)